Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

Authors: Laura Díaz-Gil, Fara Brasó-Maristany, Claudriana Locatelli, Ariana Centa, Balász Győrffy, Alberto Ocaña, Aleix Prat, Atanasio Pandiella

Published: 2021-10-07

DOI: 10.1186/s13046-021-02098-z

Source: Full article